ReP USP - Resultado da busca

Artigo de periodico
miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps (2021)
Silveira, Mariana L. C.; Tamashiro, Edwin; Santos, Anemari R. D.; Martins, Ronaldo B.; Faria, Francesca M.; Silva, Lilian E. C. M.; Torrieri, Raul; Ruy, Patricia de C.; Silva Júnior, Wilson Araújo da; Arruda, Eurico; Anselmo-Lima, Wilma Terezinha; Valera, Fabiana Cardoso Pereira
Fonte: Rhinology Journal. Unidades: FMRP, SVOI
Assuntos: DOENÇA CRÔNICA, MICRORNAS, PÓLIPOS NASAIS, SINUSITE, RINITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Mariana L. C. et al. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps. Rhinology Journal, v. 59, n. 6, p. 567-576, 2021Tradução . . Disponível em: https://doi.org/10.4193/Rhin21.109. Acesso em: 15 jul. 2024.
APA
Silveira, M. L. C., Tamashiro, E., Santos, A. R. D., Martins, R. B., Faria, F. M., Silva, L. E. C. M., et al. (2021). miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps. Rhinology Journal, 59( 6), 567-576. doi:10.4193/Rhin21.109
NLM
Silveira MLC, Tamashiro E, Santos ARD, Martins RB, Faria FM, Silva LECM, Torrieri R, Ruy P de C, Silva Júnior WA da, Arruda E, Anselmo-Lima WT, Valera FCP. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps [Internet]. Rhinology Journal. 2021 ; 59( 6): 567-576.[citado 2024 jul. 15 ] Available from: https://doi.org/10.4193/Rhin21.109
Vancouver
Silveira MLC, Tamashiro E, Santos ARD, Martins RB, Faria FM, Silva LECM, Torrieri R, Ruy P de C, Silva Júnior WA da, Arruda E, Anselmo-Lima WT, Valera FCP. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps [Internet]. Rhinology Journal. 2021 ; 59( 6): 567-576.[citado 2024 jul. 15 ] Available from: https://doi.org/10.4193/Rhin21.109
Trabalho de evento-resumo
Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer (2021)
Souza, Luiz Paulo Chaves de; Costa, André Luiz Caliari ; Dutra, William Lautert; Melo, Camila Morais ; Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago; Saggioro, Fabiano Pinto; Reis, Rodolfo Borges dos; Squire, Jeremy Andrew
Fonte: Resumos. Nome do evento: Congresso Brasileiro de Genética = Brazilian Congress of Genetics. Unidades: SVOI, FMRP
Assuntos: TRANSCRIÇÃO, NEOPLASIAS, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. 2021, Anais.. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG, 2021. Disponível em: https://www.sbg.org.br/anais. Acesso em: 15 jul. 2024.
APA
Souza, L. P. C. de, Costa, A. L. C., Dutra, W. L., Melo, C. M., Albuquerque, C. G. P. de, Vidotto, T., et al. (2021). Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer. In Resumos. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG. Recuperado de https://www.sbg.org.br/anais
NLM
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 jul. 15 ] Available from: https://www.sbg.org.br/anais
Vancouver
Souza LPC de, Costa ALC, Dutra WL, Melo CM, Albuquerque CGP de, Vidotto T, Saggioro FP, Reis RB dos, Squire JA. Analysis of the relationships between ZEB1, PTEN loss, TMPRSS2-ERG fusion and immune response biomarkers in Prostate Cancer [Internet]. Resumos. 2021 ;[citado 2024 jul. 15 ] Available from: https://www.sbg.org.br/anais
Artigo de periodico
Complete endoscopic resection of low-grade nasopharyngeal papillary adenocarcinoma: a case report (2021)
Compagnoni, Inaê Mattoso; Lamounier, Lorena Andrade; Fontanini, Letícia; Silveira, Gabriela Tosta; Faria, Francesca Maia; Reis, Maristella B. Francisco dos; Valera, Fabiana Cardoso Pereira
Fonte: Brazilian Journal of Otorhinolaryngology. Unidades: SVOI, FMRP, FORP
Assuntos: ADENOCARCINOMA PAPILAR, ENDOSCOPIA, DIAGNÓSTICO POR IMAGEM, NEOPLASIAS NASOFARINGEAS, NASOFARINGE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMPAGNONI, Inaê Mattoso et al. Complete endoscopic resection of low-grade nasopharyngeal papillary adenocarcinoma: a case report. Brazilian Journal of Otorhinolaryngology, v. 87, n. 2, p. 237-240, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bjorl.2020.10.004. Acesso em: 15 jul. 2024.
APA
Compagnoni, I. M., Lamounier, L. A., Fontanini, L., Silveira, G. T., Faria, F. M., Reis, M. B. F. dos, & Valera, F. C. P. (2021). Complete endoscopic resection of low-grade nasopharyngeal papillary adenocarcinoma: a case report. Brazilian Journal of Otorhinolaryngology, 87( 2), 237-240. doi:10.1016/j.bjorl.2020.10.004
NLM
Compagnoni IM, Lamounier LA, Fontanini L, Silveira GT, Faria FM, Reis MBF dos, Valera FCP. Complete endoscopic resection of low-grade nasopharyngeal papillary adenocarcinoma: a case report [Internet]. Brazilian Journal of Otorhinolaryngology. 2021 ; 87( 2): 237-240.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.bjorl.2020.10.004
Vancouver
Compagnoni IM, Lamounier LA, Fontanini L, Silveira GT, Faria FM, Reis MBF dos, Valera FCP. Complete endoscopic resection of low-grade nasopharyngeal papillary adenocarcinoma: a case report [Internet]. Brazilian Journal of Otorhinolaryngology. 2021 ; 87( 2): 237-240.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.bjorl.2020.10.004
Artigo de periodico
Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics (2021)
Souza, Luiz Paulo Chaves de; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Fonte: Genes. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS PROSTÁTICAS, IMUNOTERAPIA, ONCOGENES, GENES SUPRESSORES DE TUMOR, MUTAÇÃO GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, v. 12, n. 12, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/genes12121900. Acesso em: 15 jul. 2024.
APA
Souza, L. P. C. de, Melo, C. M., Saggioro, F. P., Reis, R. B. dos, & Squire, J. A. (2021). Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, 12( 12), 1-18. doi:10.3390/genes12121900
NLM
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 jul. 15 ] Available from: https://doi.org/10.3390/genes12121900
Vancouver
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 jul. 15 ] Available from: https://doi.org/10.3390/genes12121900
Trabalho de evento-resumo periodico
ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer (2021)
Souza, Luiz Paulo Chaves; Costa, André Luiz Caliari ; Melo, Camila Morais ; Saggioro, Fabiano Pinto ; Squire, Jeremy Andrew
Fonte: Cancer Research. Nome do evento: Proceedings of the American Association for Cancer Research Annual Meeting. Unidades: SVOI, FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, MUTAÇÃO GENÉTICA, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves et al. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.AM2021-1818. Acesso em: 15 jul. 2024. , 2021
APA
Souza, L. P. C., Costa, A. L. C., Melo, C. M., Saggioro, F. P., & Squire, J. A. (2021). ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer. Cancer Research. Philadelphia: , Universidade de São Paulo. doi:10.1158/1538-7445.AM2021-1818
NLM
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 jul. 15 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Vancouver
Souza LPC, Costa ALC, Melo CM, Saggioro FP, Squire JA. ZEB1 expression is associated with the PTEN loss and TMPRSS2 ERG fusion immune evasion phenotype in prostate cancer [Internet]. Cancer Research. 2021 ; 81[citado 2024 jul. 15 ] Available from: https://doi.org/10.1158/1538-7445.AM2021-1818
Artigo de periodico
PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells (2019)
Vidotto, Thiago ; Saggioro, Fabiano Pinto ; Jamaspishvili, Tamara; Chesca, Deise Lúcia; Albuquerque, Clarissa Gondim Picanço de; Reis, Rodolfo Borges dos ; Graham, Charles H.; Berman, David M.; Siemens, D. Robert; Squire, Jeremy Andrew ; Koti, Madhuri
Fonte: The Prostate. Unidades: SVOI, FMRP
Assuntos: PRÓSTATA, NEOPLASIAS, SISTEMA IMUNE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, v. 79, n. 9, p. 969-979, 2019Tradução . . Disponível em: https://doi.org/10.1002/pros.23808. Acesso em: 15 jul. 2024.
APA
Vidotto, T., Saggioro, F. P., Jamaspishvili, T., Chesca, D. L., Albuquerque, C. G. P. de, Reis, R. B. dos, et al. (2019). PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, 79( 9), 969-979. doi:10.1002/pros.23808
NLM
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1002/pros.23808
Vancouver
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1002/pros.23808
Artigo de periodico
PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features (2019)
Albuquerque, Clarissa Gondim Picanço de; Vidotto, Thiago ; Pereira, C. S.; Saggioro, Fabiano Pinto ; Jamaspishvili, T.; Koti, M.; Berman, D. M.; Squire, Jeremy Andrew ; Reis, Rodolfo Borges dos
Fonte: Applied Cancer Research. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS DOS GENITAIS MASCULINOS, ESCORE DO TESTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, Clarissa Gondim Picanço de et al. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, v. 39, 2019Tradução . . Disponível em: https://doi.org/10.1186/s41241-018-0071-y. Acesso em: 15 jul. 2024.
APA
Albuquerque, C. G. P. de, Vidotto, T., Pereira, C. S., Saggioro, F. P., Jamaspishvili, T., Koti, M., et al. (2019). PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features. Applied Cancer Research, 39. doi:10.1186/s41241-018-0071-y
NLM
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 jul. 15 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Vancouver
Albuquerque CGP de, Vidotto T, Pereira CS, Saggioro FP, Jamaspishvili T, Koti M, Berman DM, Squire JA, Reis RB dos. PTEN loss in Gleason grade 7 prostate tumors exhibits intratumoral heterogeneity and is associated with unfavorable pathological features [Internet]. Applied Cancer Research. 2019 ; 39[citado 2024 jul. 15 ] Available from: https://doi.org/10.1186/s41241-018-0071-y
Artigo de periodico
Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas (2019)
Leal, Letícia Ferro ; Cavagna, Rodrigo de Oliveira; Campanella, Nathalia Cristina; Mançano, Bruna; Almeida, Gisele Caravina; Matsushita, Marcus; Almeida Junior, Carlos Roberto; Saggioro, Fabiano Pinto ; Stavale, João Norberto; Malheiros, Suzana M. F.; Lima, Matheus; Hajj, Glaucia N. M.; Neder, Luciano ; Reis, Rui Manuel
Fonte: Journal of Neuropathology and Experimental Neurology. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS CEREBRAIS, MEDULOBLASTOMA, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas. Journal of Neuropathology and Experimental Neurology, v. 78, n. 9, p. 788-790, 2019Tradução . . Disponível em: https://doi.org/10.1093/jnen/nlz066. Acesso em: 15 jul. 2024.
APA
Leal, L. F., Cavagna, R. de O., Campanella, N. C., Mançano, B., Almeida, G. C., Matsushita, M., et al. (2019). Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas. Journal of Neuropathology and Experimental Neurology, 78( 9), 788-790. doi:10.1093/jnen/nlz066
NLM
Leal LF, Cavagna R de O, Campanella NC, Mançano B, Almeida GC, Matsushita M, Almeida Junior CR, Saggioro FP, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Neder L, Reis RM. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas [Internet]. Journal of Neuropathology and Experimental Neurology. 2019 ; 78( 9): 788-790.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1093/jnen/nlz066
Vancouver
Leal LF, Cavagna R de O, Campanella NC, Mançano B, Almeida GC, Matsushita M, Almeida Junior CR, Saggioro FP, Stavale JN, Malheiros SMF, Lima M, Hajj GNM, Neder L, Reis RM. Lack of KBTBD4 mutations in molecularly classified brazilian medulloblastomas [Internet]. Journal of Neuropathology and Experimental Neurology. 2019 ; 78( 9): 788-790.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1093/jnen/nlz066
Artigo de periodico
MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter (2019)
Darrigo Júnior, Luiz Guilherme ; Lira, Régia Caroline Peixoto ; Fedatto, Paola Fernanda ; Marco Antonio, David Santos ; Valera, Elvis Terci ; Aguiar, Simone; Yunes, Jose Andres ; Brandalise, Silvia Regina; Neder, Luciano ; Saggioro, Fabiano Pinto ; Becker, Aline Paixão ; Oliveira, Ricardo Santos de; Machado, Hélio Rubens; Panepucci, Rodrigo Alexandre ; Tone, Luiz Gonzaga ; Scrideli, Carlos Alberto
Fonte: Journal of Neuro-Oncology. Unidades: FMRP, SVOI
Assuntos: NEUROFIBROMATOSES, ASTROCITOMA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARRIGO JÚNIOR, Luiz Guilherme et al. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, v. 141, n. 2, p. 373-382, 2019Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-03042-6. Acesso em: 15 jul. 2024.
APA
Darrigo Júnior, L. G., Lira, R. C. P., Fedatto, P. F., Marco Antonio, D. S., Valera, E. T., Aguiar, S., et al. (2019). MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. Journal of Neuro-Oncology, 141( 2), 373-382. doi:10.1007/s11060-018-03042-6
NLM
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Vancouver
Darrigo Júnior LG, Lira RCP, Fedatto PF, Marco Antonio DS, Valera ET, Aguiar S, Yunes JA, Brandalise SR, Neder L, Saggioro FP, Becker AP, Oliveira RS de, Machado HR, Panepucci RA, Tone LG, Scrideli CA. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter [Internet]. Journal of Neuro-Oncology. 2019 ; 141( 2): 373-382.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1007/s11060-018-03042-6
Artigo de periodico
Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma (2018)
Leal, Letícia Ferro; Evangelista, Adriane Feijó; Paula, Flávia Escremim de; Almeida, Gisele Caravina de; Carloni, Adriana C.; Saggioro, Fabiano Pinto; Stavale, João Norberto; Malheiros, Suzana Maria Fleury; Mançano, Bruna; Oliveira, Marco A. de; Luu, Betty; Neder, Luciano; Taylor, Michael D.; Reis, Rui Manuel
Fonte: Neuropathology. Unidades: SVOI, FMRP
Assuntos: MEDULOBLASTOMA, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia Ferro et al. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, v. 38, n. 5, p. 475-483, 2018Tradução . . Disponível em: https://doi.org/10.1111/neup.12508. Acesso em: 15 jul. 2024.
APA
Leal, L. F., Evangelista, A. F., Paula, F. E. de, Almeida, G. C. de, Carloni, A. C., Saggioro, F. P., et al. (2018). Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, 38( 5), 475-483. doi:10.1111/neup.12508
NLM
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1111/neup.12508
Vancouver
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1111/neup.12508
Artigo de periodico
Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups (2018)
Salomão, Karina Bezerra; Cruzeiro, Gustavo Alencastro Veiga; Silva, Ricardo Bonfim; Geron, Lenisa; Ramalho, Fernando Silva; Saggioro, Fabiano Pinto; Neder, Luciano; Moreno, Daniel Antunes; Queiroz, Rosane Gomes de Paula; Aguiar, Simone dos Santos; Cardinalli, Izilda; Yunes, José Andres; Brandalise, Silvia Regina; Brassesco, Maria Sol; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Fonte: Journal of Neuro-Oncology. Unidades: FMRP, SVOI, FFCLRP
Assuntos: MEDULOBLASTOMA, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALOMÃO, Karina Bezerra et al. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, v. 139, n. 1, p. 33-42, 2018Tradução . . Disponível em: https://doi.org/10.1007/s11060-018-2845-1. Acesso em: 15 jul. 2024.
APA
Salomão, K. B., Cruzeiro, G. A. V., Silva, R. B., Geron, L., Ramalho, F. S., Saggioro, F. P., et al. (2018). Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups. Journal of Neuro-Oncology, 139( 1), 33-42. doi:10.1007/s11060-018-2845-1
NLM
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Vancouver
Salomão KB, Cruzeiro GAV, Silva RB, Geron L, Ramalho FS, Saggioro FP, Neder L, Moreno DA, Queiroz RG de P, Aguiar S dos S, Cardinalli I, Yunes JA, Brandalise SR, Brassesco MS, Scrideli CA, Tone LG. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups [Internet]. Journal of Neuro-Oncology. 2018 ; 139( 1): 33-42.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1007/s11060-018-2845-1
Artigo de periodico
Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome (2018)
Josahkian, Juliana A.; Saggioro, Fabiano Pinto; Vidotto, Thiago; Ventura, Henrique Torres; Reis, Francisco José Cândido dos; Sousa, Christiâni Bisinoto de; Tiezzi, Daniel Guimarães; Andrade, Jurandyr Moreira de; Koti, Madhuri; Squire, Jeremy Andrew
Fonte: International Journal of Gynecological Cancer. Unidades: SVOI, FMRP
Assuntos: BIOMARCADORES, ESTUDOS DE COORTES, IMUNOHISTOQUÍMICA, NEOPLASIAS OVARIANAS, FATORES DE RISCO, FATORES DE TRANSCRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOSAHKIAN, Juliana A. et al. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, v. 28, n. 3, p. 459-465, 2018Tradução . . Disponível em: https://doi.org/10.1097/igc.0000000000001193. Acesso em: 15 jul. 2024.
APA
Josahkian, J. A., Saggioro, F. P., Vidotto, T., Ventura, H. T., Reis, F. J. C. dos, Sousa, C. B. de, et al. (2018). Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome. International Journal of Gynecological Cancer, 28( 3), 459-465. doi:10.1097/igc.0000000000001193
NLM
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Vancouver
Josahkian JA, Saggioro FP, Vidotto T, Ventura HT, Reis FJC dos, Sousa CB de, Tiezzi DG, Andrade JM de, Koti M, Squire JA. Increased STAT1 expression in high grade serous ovarian cancer is associated with a better outcome [Internet]. International Journal of Gynecological Cancer. 2018 ; 28( 3): 459-465.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1097/igc.0000000000001193
Artigo de periodico
Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions (2018)
Yamanaka, Yasmin; Yamashita, Mauricio Eiji de Almeida Santos; Innocentini, Lara Maria ALencar Ramos; Macedo, Leandro D.; Chahud, Fernando; Ribeiro-Silva, Alfredo; Roselino, Ana Maria Ferreira; Rocha, Maria José Alves da; Motta, Ana Carolina Fragoso
Fonte: The American Journal of Dermatopathology. Unidades: FORP, FMRP, SVOI
Assuntos: IMUNOFLUORESCÊNCIA, LÍQUEN PLANO BUCAL, PATOLOGIA BUCAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMANAKA, Yasmin et al. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions. The American Journal of Dermatopathology, v. 40, n. 7, p. 491-497, 2018Tradução . . Disponível em: https://doi.org/10.1097/dad.0000000000001071. Acesso em: 15 jul. 2024.
APA
Yamanaka, Y., Yamashita, M. E. de A. S., Innocentini, L. M. A. L. R., Macedo, L. D., Chahud, F., Ribeiro-Silva, A., et al. (2018). Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions. The American Journal of Dermatopathology, 40( 7), 491-497. doi:10.1097/dad.0000000000001071
NLM
Yamanaka Y, Yamashita ME de AS, Innocentini LMALR, Macedo LD, Chahud F, Ribeiro-Silva A, Roselino AMF, Rocha MJA da, Motta ACF. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 7): 491-497.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1097/dad.0000000000001071
Vancouver
Yamanaka Y, Yamashita ME de AS, Innocentini LMALR, Macedo LD, Chahud F, Ribeiro-Silva A, Roselino AMF, Rocha MJA da, Motta ACF. Direct immunofluorescence as a helpful tool for the differential diagnosis of oral lichen planus and oral lichenoid lesions [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 7): 491-497.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1097/dad.0000000000001071
Artigo de periodico
Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature (2018)
El-Achkar, Vivian Narana Ribeiro; Duarte, Andressa; Saggioro, Fabiano Pinto; Mello-Filho, Francisco Veríssimo; León, Jorge Esquiche; Ribeiro-Silva, Alfredo; Kaminagakura, Estela
Fonte: Case Reports in Otolaryngology. Unidades: FMRP, SVOI, FORP
Assuntos: OTORRINOLARINGOLOGIA, CARCINOMA DE CÉLULAS ESCAMOSAS, LARINGE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EL-ACHKAR, Vivian Narana Ribeiro et al. Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature. Case Reports in Otolaryngology, v. 2018, 2018Tradução . . Disponível em: https://doi.org/10.1155/2018/4362162. Acesso em: 15 jul. 2024.
APA
El-Achkar, V. N. R., Duarte, A., Saggioro, F. P., Mello-Filho, F. V., León, J. E., Ribeiro-Silva, A., & Kaminagakura, E. (2018). Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature. Case Reports in Otolaryngology, 2018. doi:10.1155/2018/4362162
NLM
El-Achkar VNR, Duarte A, Saggioro FP, Mello-Filho FV, León JE, Ribeiro-Silva A, Kaminagakura E. Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature [Internet]. Case Reports in Otolaryngology. 2018 ; 2018[citado 2024 jul. 15 ] Available from: https://doi.org/10.1155/2018/4362162
Vancouver
El-Achkar VNR, Duarte A, Saggioro FP, Mello-Filho FV, León JE, Ribeiro-Silva A, Kaminagakura E. Squamous cell carcinoma originating from adult laryngeal papillomatosis: case report and review of the literature [Internet]. Case Reports in Otolaryngology. 2018 ; 2018[citado 2024 jul. 15 ] Available from: https://doi.org/10.1155/2018/4362162
Artigo de periodico
Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas (2018)
Jucá, Carlos Eduardo Barros; Colli, Leandro Machado; Martins, Clarissa Silva; Campanini, Marina Lanciotti; Paixão, Beatriz; Jucá, Renata Viana; Saggioro, Fabiano Pinto; Oliveira, Ricardo Santos de; Moreira, Ayrton Custódio; Machado, Hélio Rubens; Neder, Luciano; Antonini, Sonir Roberto Rauber; Castro, Margaret de
Fonte: Hormone and Metabolic Research. Unidades: FMRP, SVOI
Assuntos: NEOPLASIAS CEREBRAIS, GLÂNDULA PITUITÁRIA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JUCÁ, Carlos Eduardo Barros et al. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, v. 50, n. 7, p. 575-581, 2018Tradução . . Disponível em: https://doi.org/10.1055/a-0593-5956. Acesso em: 15 jul. 2024.
APA
Jucá, C. E. B., Colli, L. M., Martins, C. S., Campanini, M. L., Paixão, B., Jucá, R. V., et al. (2018). Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas. Hormone and Metabolic Research, 50( 7), 575-581. doi:10.1055/a-0593-5956
NLM
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1055/a-0593-5956
Vancouver
Jucá CEB, Colli LM, Martins CS, Campanini ML, Paixão B, Jucá RV, Saggioro FP, Oliveira RS de, Moreira AC, Machado HR, Neder L, Antonini SRR, Castro M de. Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas [Internet]. Hormone and Metabolic Research. 2018 ; 50( 7): 575-581.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1055/a-0593-5956
Artigo de periodico
Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report (2018)
Vanzela, Tamara de Nardo; Bernardes Filho, Fred; Wambier, Carlos Gustavo; Faria, Francesca Maia; Foss, Norma Tiraboschi; Frade, Marco Andrey Cipriani
Fonte: The American Journal of Dermatopathology. Unidades: SVOI, FMRP
Assuntos: HIPERSENSIBILIDADE A DROGAS, HANSENÍASE, LINFÓCITOS T, INTERLEUCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VANZELA, Tamara de Nardo et al. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report. The American Journal of Dermatopathology, v. 40, n. 3, p. 205-208, 2018Tradução . . Disponível em: https://doi.org/10.1097/dad.0000000000000839. Acesso em: 15 jul. 2024.
APA
Vanzela, T. de N., Bernardes Filho, F., Wambier, C. G., Faria, F. M., Foss, N. T., & Frade, M. A. C. (2018). Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report. The American Journal of Dermatopathology, 40( 3), 205-208. doi:10.1097/dad.0000000000000839
NLM
Vanzela T de N, Bernardes Filho F, Wambier CG, Faria FM, Foss NT, Frade MAC. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 3): 205-208.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1097/dad.0000000000000839
Vancouver
Vanzela T de N, Bernardes Filho F, Wambier CG, Faria FM, Foss NT, Frade MAC. Th17 response of borderline-lepromatous leprosy inhibits rash manifestation of Dapsone Hypersensitivity Syndrome: case report [Internet]. The American Journal of Dermatopathology. 2018 ; 40( 3): 205-208.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1097/dad.0000000000000839
Artigo de periodico
Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection (2018)
Petrilli, Raquel; Eloy, Josimar de Oliveira ; Saggioro, Fabiano Pinto ; Chesca, Deise Lúcia; Souza, Marina Claro de; Dias, Marcos Vinicios Salles; Silva, Luis Lamberti Pinto da ; Lee, Robert J.; Lopez, Renata Fonseca Vianna
Fonte: Journal of Controlled Release. Unidades: SVOI, FMRP, FCFRP
Assuntos: MODELOS ANIMAIS, CARCINOMA DE CÉLULAS ESCAMOSAS, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, v. 283, p. 151-162, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2018.05.038. Acesso em: 15 jul. 2024.
APA
Petrilli, R., Eloy, J. de O., Saggioro, F. P., Chesca, D. L., Souza, M. C. de, Dias, M. V. S., et al. (2018). Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, 283, 151-162. doi:10.1016/j.jconrel.2018.05.038
NLM
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Vancouver
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Artigo de periodico
Atypical cellular blue nevus or malignant blue nevus? (2017)
Daltro, Luise Ribeiro; Yaegashi, Lygia Bertalha; Freitas, Rodrigo Abdalah; Fantini, Bruno de Carvalho; Souza, Cacilda da Silva
Fonte: Anais Brasileiros de Dermatologia. Unidades: SVOI, FMRP
Assuntos: CRIANÇAS, DIAGNÓSTICO DIFERENCIAL, NEOPLASIAS CUTÂNEAS, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DALTRO, Luise Ribeiro et al. Atypical cellular blue nevus or malignant blue nevus?. Anais Brasileiros de Dermatologia, v. 92, n. 1, p. 110-112, 2017Tradução . . Disponível em: https://doi.org/10.1590/abd1806-4841.20174502. Acesso em: 15 jul. 2024.
APA
Daltro, L. R., Yaegashi, L. B., Freitas, R. A., Fantini, B. de C., & Souza, C. da S. (2017). Atypical cellular blue nevus or malignant blue nevus? Anais Brasileiros de Dermatologia, 92( 1), 110-112. doi:10.1590/abd1806-4841.20174502
NLM
Daltro LR, Yaegashi LB, Freitas RA, Fantini B de C, Souza C da S. Atypical cellular blue nevus or malignant blue nevus? [Internet]. Anais Brasileiros de Dermatologia. 2017 ; 92( 1): 110-112.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1590/abd1806-4841.20174502
Vancouver
Daltro LR, Yaegashi LB, Freitas RA, Fantini B de C, Souza C da S. Atypical cellular blue nevus or malignant blue nevus? [Internet]. Anais Brasileiros de Dermatologia. 2017 ; 92( 1): 110-112.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1590/abd1806-4841.20174502
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Fonte: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Assuntos: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 15 jul. 2024.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 jul. 15 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Trabalho de evento-resumo
PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer (2016)
Vidotto, Thiago; Ouellet, Véronique; Saggioro, Fabiano Pinto; Caron, Christine; Fragoso, Gabriela; Mes-Masson, Anne-Marie; Saad, Fred; Siemens, D. Robert; Squire, Jeremy Andrew; Koti, Madhuri
Fonte: Abstracts. Nome do evento: Cancer Genomics Group Meetings. Unidades: SVOI, FMRP
Assuntos: NEOPLASIAS PROSTÁTICAS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. 2016, Anais.. Ontario: Queen's University, 2016. . Acesso em: 15 jul. 2024.
APA
Vidotto, T., Ouellet, V., Saggioro, F. P., Caron, C., Fragoso, G., Mes-Masson, A. -M., et al. (2016). PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. In Abstracts. Ontario: Queen's University.
NLM
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2024 jul. 15 ]
Vancouver
Vidotto T, Ouellet V, Saggioro FP, Caron C, Fragoso G, Mes-Masson A-M, Saad F, Siemens DR, Squire JA, Koti M. PTEN loss associates with STAT1/3 expression and intra-tumoral CD8+ density in prostate cancer. Abstracts. 2016 ;[citado 2024 jul. 15 ]

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada